Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian tryptophanyl-tRNA synthetase reveal link of the epitopes to aggregation and Alzheimer's disease

Molecular Immunology
Elena L PaleyGalina F Denisova

Abstract

Tryptophanyl-tRNA synthetase (TrpRS) is an interferon-induced phosphoprotein with autoantigenic and cytokine activities detected in addition to its canonical function in tRNA aminoacylation. The availability of monoclonal antibodies (mAbs) specific for TrpRS is important for development of tools for TrpRS monitoring. A molecular characterization of two mAbs raised in mice, using purified, enzymatically active bovine TrpRS as the inoculating antigen, is presented in this report. These IgG1 antibodies are specific for bovine, human and rabbit but not E. coli TrpRS. Immunoreactivity and specificity of mAbs were verified with purified recombinant hTrpRS expressed in E. coli and TrpRS-derived synthetic peptides. One of the mAbs, 9D7 is able to disaggregate fibrils formed by Ser32-Tyr50 TrpRS-peptide. Epitope mapping revealed that disaggregation ability correlates with binding of 9D7 to this peptide in ELISA and immunocytochemistry. This epitope covers a significant part of N-terminal extension that suggested to be proteolytically deleted in vivo from the full-length TrpRS whereas remaining COOH-fragment possesses a cytokine activity. For epitope mapping of mAb 6C10, the affinity selected phage-displayed peptides were used as a datab...Continue Reading

References

Feb 3, 1975·European Journal of Biochemistry·G LemaireB Labouesse
Jan 1, 1977·International Journal of Cancer. Journal International Du Cancer·A A YunisD J Russin
May 15, 1975·International Journal of Cancer. Journal International Du Cancer·M LieberG Todaro
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·F W MillerP H Plotz
Jul 1, 1991·Experimental Cell Research·E L PaleyL L Kisselev
Jun 15, 1989·Biochemical and Biophysical Research Communications·V V FilonenkoL L Kisselev
Aug 28, 1971·Journal of Molecular Biology·A K Bandyopadhyay, M P Deutscher
Jan 1, 1981·Methods in Enzymology·G Galfrè, C Milstein
Oct 1, 1996·Journal of Leukocyte Biology·S W KrauseR Andreesen
Dec 1, 1995·Immunology Letters·E L PaleyL Smelansky
Mar 15, 1997·European Journal of Biochemistry·E L Paley
May 29, 2000·The Journal of Biological Chemistry·R JorgensenJ Justesen
Sep 10, 2002·Current Rheumatology Reports·Ira N Targoff
Apr 1, 1965·Proceedings of the Society for Experimental Biology and Medicine·R N HULLO J TRITCH
Oct 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Olga SokolovaNikolaus Grigorieff
Nov 5, 2003·Journal of Molecular Biology·David Enshell-SeijffersJonathan M Gershoni
Dec 13, 2003·Proceedings of the National Academy of Sciences of the United States of America·Xiang-Lei YangLlúis Ribas de Pouplana
Mar 24, 2004·Cytokine·Masashi OhtaniNaoko Watanabe
Dec 8, 2004·The Journal of Biological Chemistry·Eleni TzimaPaul Schimmel
Apr 28, 2005·Current Drug Targets. Inflammation and Allergy·Gilbert J HoEliezer Masliah

❮ Previous
Next ❯

Citations

Jul 4, 2007·The Journal of Antimicrobial Chemotherapy·Yang WuHualiang Jiang
May 1, 2021·International Journal of Molecular Sciences·Young Ha AhnTae-Don Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.